Nitric oxide releasing high density lipoprotein-like nanoparticles (no hdl nps)
US-2020281962-A1 · Sep 10, 2020 · US
Pharmaceutical composition for prevention or treatment of kidney damage
US12220394B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-12220394-B2 |
| Application number | US-201916972898-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jun 6, 2019 |
| Priority date | Jun 7, 2018 |
| Publication date | Feb 11, 2025 |
| Grant date | Feb 11, 2025 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
The present invention pertains to a pharmaceutical composition for the prevention or treatment of kidney disease, a kidney inflammation inhibitor, an inflammatory cell death inhibitor for the kidneys, or a food for the prevention or improvement of kidney disease, that include D-alanine or a derivative thereof. In addition, the present invention pertains to the use of D-alanine or a derivative thereof, for the production of a pharmaceutical composition for the prevention or treatment of kidney disease.
First claim
Opening claim text (preview).
The invention claimed is: 1. A method for treatment of kidney disease, comprising: administrating D-alanine to a subject in need thereof, wherein the kidney disease is chronic kidney disease, ischemia-induced kidney disorder, or inflammation-induced kidney disorder. 2. The method according to claim 1 , wherein the D-alanine is used for kidney protection or restoration of kidney function. 3. The method according to claim 1 , wherein the administration is local administration, enteral administration or parenteral administration. 4. The method according to claim 1 , wherein the kidney disease is chronic kidney disease. 5. The method according to claim 1 , wherein the kidney disease is ischemia-induced kidney disorder. 6. The method according to claim 1 , wherein the kidney disease is inflammation-induced kidney disorder.
Assignees
Inventors
Classifications
Mouth and digestive tract, i.e. intraoral and peroral administration · CPC title
of the kidneys · CPC title
Amino acids · CPC title
for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis · CPC title
Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00 · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US12220394B2 cover?
- The present invention pertains to a pharmaceutical composition for the prevention or treatment of kidney disease, a kidney inflammation inhibitor, an inflammatory cell death inhibitor for the kidneys, or a food for the prevention or improvement of kidney disease, that include D-alanine or a derivative thereof. In addition, the present invention pertains to the use of D-alanine or a derivative t…
- Who is the assignee on this patent?
- Univ Nat Corp Kanazawa, Kagami Inc
- What technology area does this patent fall under?
- Primary CPC classification A61K31/198. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue Feb 11 2025 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 4 related publications on this page (citations in our corpus or others sharing the same primary CPC).